📰 Off Label Indication News
Off Label Indication News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Off Label Indication. Real-time updates on events, politics, business and more.
May 1, 2024
Denmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing so-called GLP-1 drugs such as Novo Nordisk's Ozempic, the Danish...
December 11, 2023
Despite off-label use of naltrexone by some patients with fibromyalgia in clinical practice, data from a randomized trial showed no pain relief advantage with the drug over placebo.
November 27, 2023
Novo Nordisk has announced a $2.3 billion investment to boost production of its wildly popular weight-loss and diabetes drugs at a site in Chartres, France.
November 14, 2023
The guidelines cover approved and off-label uses of systemic therapies and phototherapy, including new treatments that have become available since the last guidelines were published in 2014.
October 14, 2023
LSD use tripled among young adults with past-year depression, results from the annual National Survey on Drug Use and Health show.
September 5, 2023
The viral trend of Barbie Botox has women as young as in their 20s rush for toxin-based procedures to mimic the looks of the movies lead actress Margot Robbie.
July 25, 2023
Weight loss is recommended for patients with knee osteoarthritis (KOA), and GLP-1 RAs are approved for weight loss. Early research suggests these drugs might have a disease-modifying effect for KOA.
July 24, 2023
Those with long COVID for years now are engaging in robust online conversations about a range of treatments not formally approved by the US Food and Drug Administration for the condition.
July 5, 2023
The CamAPS FX automated insulin delivery system is approved for use in pregnant women with type 1 diabetes in Europe, and a large RCT shows it should be offered to all such women, says the lead trialist.
June 14, 2023
The study authors looked at first-time oral minoxidil prescriptions for patients at eight health care systems before and after the New York Times published an article on its off label use for hair loss.